MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma

计划入组 400 人 · 首次发布于 2015 年 3 月 11 日

Natural History Study of Moles and Suspicious Melanoma

计划入组 20 人 · 首次发布于 2006 年 2 月 8 日

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

计划入组 2,998 人 · 首次发布于 2019 年 3 月 4 日

Cutaneous indications(DeepCure)

melanoma vaccine

Melanoma(FAKnostics)

MELANOMA INSTITUTE AUSTRALIA

Australia

PRIMARY PHARMACEUTICALS, INC.

United States

Cutis Academy of Cutaneous Sciences

India

Nanobiotix's JNJ-1900 Shows Promising Results in Anti-PD-1 Resistant Melanoma Patients

Study Finds Strong Link Between Cutaneous Melanoma and Uveal Melanoma Risk

Vidutolimod and Nivolumab Combination Shows Promise in Melanoma Treatment